June 16, 2026

FDA approves Bayer’s Ambelvist contrast agent

​The US FDA has approved Bayer’s Ambelvist, a mGBCA, for use in MRI in adults and children, including term neonates.The...

June 16, 2026

ALK’s EURneffy secures MHRA approval for anaphylaxis treatment

​ALK has received marketing authorisation from the MHRA for EURneffy 1mg, a needle-free adrenaline treatment for children with anaphylaxis.The post...

June 15, 2026

Lilly reports Phase III BRUIN CLL-322 trial results for Jaypirca combo

​Eli Lilly and Company has reported results from the BRUIN CLL-322 Phase III trial, assessing Jaypirca, combined with venetoclax and...

June 15, 2026

FDA clears MSD’s Keytruda combo plus Welireg for ccRCC treatment

​MSD has received approval from the FDA for both Keytruda and Keytruda Qlex, in combination with Welireg, as an adjuvant...

June 15, 2026

Fleming Initiative and Cepheid begin TRACE-CPE study on rapid CPE testing

​The Fleming Initiative and Cepheid have begun the TRACE-CPE research study aimed at improving testing for antimicrobial resistance.The post Fleming...

June 12, 2026

First patient treated in Airiver Medical’s RESTORE-2 trial for CRS

​Airiver Medical has treated the first patient in its RESTORE-2 pivotal clinical trial assessing the ESSpand Sinus DCB for CRS.The...

June 12, 2026

Novo Nordisk identifies unauthorised data access from trials

​Novo Nordisk has identified that certain patient data from some of its clinical trials was accessed and copied externally in...

June 12, 2026

FDA grants priority review for Roche’s Tecentriq combo sBLA

​Roche has received the FDA priority review for its sBLA for adjuvant Tecentriq and Tecentriq Hybreza in combination with chemotherapy...

June 11, 2026

Sibel Health’s ANNE One platform secures EU MDR CE mark

​Sibel Health has received CE mark certification under the EU MDR for its ANNE One system, designating it as a...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.